SYNTHESIS AND PHOTOPROPERTIES OF A SUBSTITUTED ZINC(II) PHTHALOCYANINE-N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER CONJUGATE

被引:16
作者
GU, ZW
SPIKES, JD
KOPECKOVA, P
KOPECEK, J
机构
[1] UNIV UTAH,DEPT BIOENGN,2480 MEB,SALT LAKE CITY,UT 84112
[2] UNIV UTAH,DEPT BIOL,SALT LAKE CITY,UT 84112
关键词
D O I
10.1135/cccc19932321
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In cancer photodynamic therapy (PDT), improved efficiency of photosensitizer delivery to tumors may be obtained by binding them to targetable water soluble polymeric carriers. However, attachment of photosensitizers to macromolecular carriers may alter their spectral and photosensitizing properties. In this study, a new monosubstituted phthalocyanine derivative, N-glycyl zinc(II) 4,9,16,23-tetraaminophthalocyanine (G-TAPC-Zn) was synthesized by the reaction of zinc(II) 4,9,16,23-tetraaminophthalocyanine (TAPC-Zn) with N-tert-butoxycarbonyl-glycine N'-hydroxybenzotriazole ester followed by deprotection of the tert-butoxycarbonyl (BOC) group. G-TAPC-Zn contains an aliphatic amino group suitable for attachment to water soluble polymeric carriers. By aminolysis of a polymeric precursor, an N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer containing oligopeptide (GFLG) side-chains terminated in p-nitrophenyl ester groups, with G-TAPC-Zn a polymeric derivative of the latter (P-GFLGG-TAPC-Zn) was synthesized. Spectral data indicated that in aqueous solutions P-GFLGG-TAPC-Zn formed aggregates. The degree of aggregation decreased with increasing concentration of detergents or organic solvents in buffer solutions. Consequently, the release of the drug from the carrier catalyzed by thiol proteinases, papain or cathepsin B, took place only in the presence of detergents or organic solvents, i.e., under conditions with a lower probability of aggregate formation. Binding of G-TAPC-Zn to HPMA copolymers decreased the quantum yield of singlet oxygen generation from 0.24 to 0,063 and significantly increased its resistance to photobleaching.
引用
收藏
页码:2321 / 2336
页数:16
相关论文
共 37 条
  • [1] SYNTHESIS AND STRUCTURAL STUDIES OF METAL(II) 4,9,16,23-PHTHALOCYANINE TETRAAMINES
    ACHAR, BN
    FOHLEN, GM
    PARKER, JA
    KESHAVAYYA, J
    [J]. POLYHEDRON, 1987, 6 (06) : 1463 - 1467
  • [2] PHOTOACTIVATABLE DRUGS
    BAYLEY, H
    GASPARRO, F
    EDELSON, R
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (04) : 138 - 143
  • [3] PRECLINICAL EVALUATION OF POLYMER-BOUND DOXORUBICIN
    DUNCAN, R
    SEYMOUR, LW
    OHARE, KB
    FLANAGAN, PA
    WEDGE, S
    HUME, IC
    ULBRICH, K
    STROHALM, J
    SUBR, V
    SPREAFICO, F
    GRANDI, M
    RIPAMONTI, M
    FARAO, M
    SUARATO, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 1992, 19 (1-3) : 331 - 346
  • [4] QUANTUM YIELD OF SINGLET OXYGEN PRODUCTION BY XANTHENE DERIVATIVES
    GANDIN, E
    LION, Y
    VANDEVORST, A
    [J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1983, 37 (03) : 271 - 278
  • [5] GOFF BA, 1991, CANCER RES, V51, P4762
  • [6] PROPERTIES AND APPLICATIONS OF PHOTODYNAMIC THERAPY
    GOMER, CJ
    RUCKER, N
    FERRARIO, A
    WONG, S
    [J]. RADIATION RESEARCH, 1989, 120 (01) : 1 - 18
  • [7] HALL TW, 1982, NOUV J CHIM, V6, P653
  • [8] HOW DOES PHOTODYNAMIC THERAPY WORK
    HENDERSON, BW
    DOUGHERTY, TJ
    [J]. PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1992, 55 (01) : 145 - 157
  • [9] JIANG FN, 1992, J CONTROL RELEASE, V19, P41, DOI 10.1016/0168-3659(92)90064-X
  • [10] KESSEL D, 1990, PHOTODYNAMIC THERAPY, V1